Surgical Quality Improvement

Total Hip Arthroplasty Outcomes

Total Hip Arthroplasty ACS NSQIP Outcomes

January 1, 2021 – December 31, 2021

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall total hip arthroplasty ACS NSQIP performance benchmarked against 468 participating sites.

Total Hip Arthroplasty (468 sites)NObservedExpected
30 Day Mortality2900.69%0.37%
30 Day Morbidity2905.17%4.74%
Cardiac 2900.69%0.29%
Unplanned Intubation2900.69%0.21%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus2902.07%0.97%
Renal Failureᵃ2901.72%0.23%
Urinary Tract Infection (UTI)2901.03%0.67%
Surgical Site Infection (SSI)2900.69%2.09%
C.diff Colitis2900.34%0.14%
Return to Operating Room (ROR)2901.03%3.05%

American College of Surgeons National Surgical Quality Improvement Program, 2022.
ACS NSQIP® Semiannual Report July 12, 2022, Chicago: American College of Surgeons.

ᵃExemplary rating; Identified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model